Basics Liquidia Technologies, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.1B Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.38% Avg Daily Range (30 D): $0.54 | 2.24% Avg Daily Range (90 D): $0.55 | 2.72% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): 2.31M Avg Daily Volume (90 D): 2.32M Trade Size Avg Trade Size (Sh.): 102 Avg Trade Size (Sh.) (30 D): 74 Avg Trade Size (Sh.) (90 D): 78 Institutional Trades Total Inst.Trades: 824 Avg Inst. Trade: $1.92M Avg Inst. Trade (30 D): $3.95M Avg Inst. Trade (90 D): $2.96M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.21M Avg Closing Trade (30 D): $5.95M Avg Closing Trade (90 D): $4.62M Avg Closing Volume: 164.51K     News Sep 29, 2025 @ 12:30 PM Liquidia to Present Clinical Data from ASCENT Tria... Source: Globe Newswire Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.7 $-.49 $-.45 Diluted EPS $-1.7 $-.49 $-.45 Revenue $ 19.32M $ 8.84M $ 3.12M Gross Profit $ $ $ 1.6M Net Income / Loss $ -141.47M $ -41.58M $ -38.37M Operating Income / Loss $ -138.23M $ -37.51M $ -35.43M Cost of Revenue $ $ $ 1.52M Net Cash Flow $ 43.83M $ 7.17M $ -6.72M PE Ratio